In contrast to this finding, it was recently reported that activation of NF-kB inhibited (E)-2,4-Bis(p-hydroxyphenyl)-2-butenal-induced DR6 expression in colon cancer cells [42]. This evidence concerns the gene TNFRSF21 and malignant colon neoplasm.